Spectrum Pharma: Q4 Earnings Snapshot
By AP News
Published - Mar 22, 2023, 08:25 AM ET
Last Updated - Jun 22, 2023, 02:48 PM EDT
BOSTON (AP) — BOSTON (AP) — Spectrum Pharmaceuticals Inc. (SPPI) on Wednesday reported a loss of $9 million in its fourth quarter.
The Boston-based company said it had a loss of 5 cents per share. Losses, adjusted to account for discontinued operations, came to 6 cents per share.
The biotechnology company posted revenue of $10.1 million in the period.
For the year, the company reported a loss of $75.4 million, or 41 cents per share. Revenue was reported as $10.1 million.
